Health Canada Responds To Probiotics Proliferation With Revised Regulation
This article was originally published in The Tan Sheet
Executive Summary
Canada’s evolving regulatory framework for probiotics may offer lessons for the U.S., though statutes constrain how much FDA can change.
You may also be interested in...
NDI Guidance Microorganism Stance Could Strain Probiotics Development
The growth of probiotics in supplements could slow to a crawl under FDA's new dietary ingredient notification draft guidance, industry stakeholders fear.
Probiotics, Juice Disease Claims Elicit Product Seizure Response From FDA
FDA deploys harsh enforcement actions against a pair of repeat health claim offenders, directing U.S. Marshals to seize products from a probiotics firm and a winery.
OTC Probiotics Face Challenging Regulatory Framework
The development of OTC drugs based on probiotics requires a regulatory system more receptive to research on the microorganisms' use as therapeutic ingredients, according to microbiologist Gary Huffnagle.